Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, December 29, 2009, 9:48PM ET - U.S. Markets Closed. Dow Down 0.02% Nasdaq Down 0.12%
Calypte Biomedical Corp. (CBMC.PK)At 3:13PM ET: 0.0085   0.00 (0.00%)  
MORE ON CBMC.PK
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Calypte Biomedical Corp.
16290 SW Upper Boones Ferry Road
Portland, OR 97224
United States - Map
Phone: 503-726-2227
Fax: 503-601-6299
Web Site: http://www.calypte.com

DETAILS 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:1

BUSINESS SUMMARY 
Calypte Biomedical Corporation engages in the development, manufacture, and distribution of in vitro diagnostic tests primarily for the diagnosis of human immunodeficiency virus (HIV) infection. It focuses on the commercialization of HIV-1/2 rapid tests for the detection of antibodies to HIV-1 and HIV 2 in oral fluid and blood samples using a lateral flow dipstick design. The company also offers HIV-1 BED Incidence EIA Test, which detects HIV-1 infections that have occurred within approximately the prior six months, and could be used by public health agencies to identify those regions and the populations within them where HIV transmission is occurring most recently. Calypte Biomedical, through its 51%-owned joint ventures, Beijing Calypte Biomedical Technology Ltd. and Beijing Marr Bio-Pharmaceutical Co., Ltd., manufactures and markets its products in China. The company was founded in 1988 and is headquartered in Portland, Oregon.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Calypte Biomedical Corp.


    CORPORATE GOVERNANCE 
    Calypte Biomedical Corp.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 83.5% of CGQ Universe companies and 65.4% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Adel Karas , 65
    Chief Exec. Officer, Pres, Chief Financial Officer, Sec., Independent Director and Member of Nominating & Governance Committee
    N/A N/A
    Dr. Ronald W. Mink Ph.D, 56
    Chief Science Officer
    $ 234.00KN/A
    Mr. Jerrold D. Dotson , 56
    Consultant
    $ 165.00KN/A
    Ms. Khatuna Janjalia ,
    Pres of Geneva Branch Office
    N/A N/A
    Mr. J. Daniel Clark , 63
    VP of Sales and Marketing
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis